Tositumomab Alternatives Compared
Tositumomab | Rituxan (rituximab) | Rituximab |
|
---|
Tositumomab | Rituxan (rituximab) | Rituximab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Diagnosis and Investigation, Non-Hodgkin's Lymphoma. Tositumomab may also be used for purposes not listed in this medication guide. |
Prescription only
Rituxan is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid... View more |
Prescription only
Rituximab (brand name Rituxan) is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia... View more |
Related suggestions Non-Hodgkin's Lymphoma
|
|||||||
More about Rituxan (rituximab) | More about Rituximab | |||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Rituxan has an average rating of 8.3 out of 10 from a total of 52 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 10% reported a negative effect. |
Rituximab has an average rating of 7.7 out of 10 from a total of 171 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Tositumomab side effects |
View all Rituxan side effects |
View all Rituximab side effects |
||||||||
Drug Class | ||||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Rituxan prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
Bexxar Dosimetric, BexxarTherapeutic | Other rituximab brands include: Riabni, Ruxience, Truxima | Riabni, Rituxan, Ruxience, Truxima | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
N/A |
59.8 hours |
59.8 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 293 drugs are known to interact with Tositumomab:
|
A total of 192 drugs are known to interact with Rituxan:
|
A total of 192 drugs are known to interact with Rituximab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
First Approval Date | ||||||||||
N/A |
November 26, 1997 |
N/A |
||||||||
WADA Class View classifications | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient Resources | ||||||||||
N/A |
||||||||||
Professional Resources | ||||||||||
N/A |
||||||||||
Related Treatment Guide | ||||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Lexiscan
Lexiscan is used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Baqsimi
Baqsimi is used to treat very low blood sugar (severe hypoglycemia) in adults and children aged 1 ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Gvoke
Gvoke injection is used to treat severe hypoglycemia (low blood sugar) in patients with diabetes ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.